Developer docs
API playgroundTry for free, no card

Search company profiles

SyntheticMR

Full company profile

uuid0007uks

Namestring
SyntheticMR
Legal namestring
SyntheticMR AB
Websiteurl
syntheticmr.com
Company typeenum
Public
Founded yearint
2007
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLinköping, Sweden
HQ citystring
Linköping
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
quantitative MRI software, synthetic MRI imaging, brain tissue segmentation, medical imaging software, neuroimaging analysis
Industry4 codes
PRIMARYHLACANAD
Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAF
SaMD – Digital Biomarkers & Algorithmic Endpoints
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code1 code
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Imaging Software (Quantitative MRI)
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Software License Sales
TypeSubscription Recurring
Description

SyMRI software sold as product packages (SyMRI NEURO, SyMRI MSK) through direct sales and channel partners. Revenue from software licenses, potentially recurring maintenance/upgrades.

syntheticmr.com
2OEM Licensing (GE Healthcare - MAGiC)
TypeLicensing Royalties
Description

Customized version of SyMRI IMAGE marketed and sold by GE Healthcare under license agreement. Generates licensing/royalty revenue.

syntheticmr.com
3Acquisition Integration (Combinostics)
TypeSubscription Recurring
Description

Acquired Combinostics Oy in January 2025 for EUR 4.3 million to integrate cNeuro platform and strengthen AI-based neuroimaging capabilities.

news.cision.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels9 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1SyMRI
Description

Quantitative MRI software delivering multiple adjustable contrast images and quantitative data from a single scan. Available in different packages including SyMRI NEURO (brain imaging with tissue segmentation and volumetric measurements), SyMRI MSK (knee and spine imaging), and SyMRI IMAGE (general imaging).

syntheticmr.com
+3 more records
Core offering1 text field

SyntheticMR develops and markets SyMRI, a quantitative MRI software platform that produces multiple adjustable contrast-weighted images and absolute tissue property measurements (T1, T2, PD maps) plus automatic brain tissue and myelin segmentations from a single 5-minute MRI scan. The platform is sold in clinically focused packages (SyMRI NEURO for brain imaging, SyMRI MSK for knee and spine, SyMRI IMAGE / MAGiC standard package) and complemented by the cNeuro AI clinical decision-support platform (acquired from Combinostics Oy) for differential diagnosis of cognitive and neurodegenerative disorders.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 5-minute scan time vs. multiple conventional sequences
+4 more records
Product overview1 text field

SyntheticMR develops and markets SyMRI, an innovative MRI software platform that delivers multiple adjustable contrast images and quantitative data from a single 5-minute scan. The product portfolio includes SyMRI NEURO (advanced brain imaging with automatic tissue segmentation and myelin quantification, CE-marked and FDA 510(k) cleared), SyMRI MSK (musculoskeletal imaging for knee and spine, CE-marked), and SyMRI IMAGE (standard package with multiple contrast images). The company also offers SyMRI 3D and SyMRI 15 as newer generations. Through its acquisition of Combinostics Oy in January 2025, SyntheticMR expanded to include the cNeuro AI-driven platform with modules for cMRI, cDSI, cPET, and cDAT, combining quantitative MRI with AI-powered clinical decision support for neurological diagnostics. A licensed version, MAGiC, is distributed by GE Healthcare under a license agreement.

Product and service5 records
1SyMRI NEURO
CategoryQuantitative brain MRI software
Description

Advanced quantitative brain MRI software package that delivers multiple adjustable contrast-weighted images, automatic tissue segmentation (WM, GM, CSF, myelin), volumetric measurements, parametric T1/T2/PD maps and REMyDI myelin quantification from a single scan. CE-marked under EU MDR 2017/745 and FDA 510(k) cleared. Designed for neuroradiology departments, neurology departments and cognitive/memory clinics diagnosing and monitoring MS, dementia, brain tumors, ALS, stroke and pediatric neurological conditions.

2SyMRI MSK (Spine / Knee)
CategoryMusculoskeletal MRI software
Description

Quantitative musculoskeletal MRI software package delivering multiple contrast-weighted images (T1W, T2W, PDW, STIR) and quantitative T1, T2 and PD maps for knee and spine anatomies in a single 6-minute acquisition. CE-marked. Used by orthopedic and MSK radiologists for cartilage, spine and spinal cord assessment.

3SyMRI IMAGE
CategoryQuantitative MRI software (standard package)
Description

Standard quantitative MRI software package delivering up to 8 contrast-weighted images (T1W, T2W, T2W FLAIR, Double Inversion Recovery, Phase Sensitive Inversion Recovery) from a single 6-minute scan, designed to speed up clinical MRI workflow for general imaging use.

4MAGiC
CategoryOEM-licensed quantitative MRI software
Description

Customer-specific version of SyMRI IMAGE marketed and sold globally by GE Healthcare under a license agreement with SyntheticMR. Available on GE Healthcare's SIGNA MRI systems including SIGNA Pioneer. Generates licensing/royalty revenue for SyntheticMR through OEM distribution.

5cNeuro
CategoryAI neuroimaging decision support platform
Description

AI-driven clinical decision support platform acquired with Combinostics Oy in January 2025. Combines quantitative MRI data with clinical data to support differential diagnosis and disease progression prediction in cognitive disorders such as Alzheimer's and other dementias. Comprises the modules cMRI (automated MRI brain image analysis), cDSI (diagnostic support), cPET (PET image analysis) and cDAT (SPECT/DaTscan analysis), supporting interdisciplinary neurology, radiology and nuclear medicine workflows.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

GE Healthcare markets and sells MAGiC, a customer-specific version of SyMRI IMAGE, under a license agreement. MAGiC is available on GE's SIGNA MRI systems including the SIGNA Pioneer. This is a flagship OEM partnership generating licensing revenue and global distribution through GE's installed base.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

SyMRI NEURO is available on syngo.via Open Apps from Siemens Healthineers. Collaboration has expanded from initial agreement to direct availability through Siemens Healthineers globally. Also integrated with Siemens Healthineers' Digital Ecosystem.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Global agreement for inclusion of SyMRI in Philips' third party product catalogue. Expanded partnership for SyMRI 3D with joint marketing. SyMRI NEURO compatible with Philips SmartSpeed for accelerated imaging.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint development project with Juntendo University Hospital and Canon Medical Systems for SyMRI 3D development. SyMRI compatible with Canon MRI scanners through this partnership.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Partnership agreement and first order received for SyMRI integration with United Imaging MRI systems.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

SyMRI product available in Fujifilm's Synapse PACS solution for customers in Japan, providing additional distribution channel in Japanese market.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

SyMRI sold through partnership agreements with Sectra for PACS integration.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

North American partnership for utilization of SyMRI technology across multiple SimonMed imaging sites. Expanded trials of synthetic MRI testing and expansion of availability.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Integration of SyMRI to support neuropsychiatric research in mood and anxiety disorders using quantitative MRI measures.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Collaboration agreement for SyMRI utilization in India.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clinical collaboration using SyMRI in pediatric MRI examinations. Dr. Leach leading quantitative MRI implementation for brain development assessment.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Integration of SyMRI into clinical workflow at ProScan Imaging facilities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Acquired January 2, 2025 for EUR 4.3 million to integrate Combinostics' cNeuro platform (cMRI, cDSI, cPET, cDAT) and strengthen AI-based neuroimaging capabilities. Jussi Mattila, former CTO of Combinostics, now CTO of SyntheticMR.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global MRI OEM and SyntheticMR's flagship licensing partner — markets MAGiC (a customized version of SyMRI IMAGE) on SIGNA scanners. Directly comparable as a large-scale MRI hardware-and-software incumbent whose AI roadmap overlaps with SyntheticMR's quantitative imaging niche.

TypeBroad incumbent
Description

Global MRI OEM and reseller of SyMRI NEURO via syngo.via Open Apps. Comparable as a broad incumbent offering AI-enabled imaging suites (AI-Rad Companion) that overlap with SyntheticMR's clinical-decision-support positioning.

TypeBroad incumbent
Description

Global MRI OEM with SyMRI integration through SmartSpeed AI-accelerated imaging and the third-party catalogue. Comparable as a broad incumbent whose AI imaging portfolio competes for the same radiology-department budgets.

TypeDirect peer
Description

Belgian specialist in AI-based brain MRI quantification (icobrain) for MS, dementia and traumatic brain injury. Direct peer because it offers MRI brain quantification and clinical decision support in the same neurology workflows SyntheticMR targets with SyMRI NEURO and cNeuro.

TypeDirect peer
Description

US-based developer of quantitative MRI post-processing software (NeuroQuant, LesionQuant) for brain volumetrics and lesion tracking. Direct peer because it sells quantitative MRI biomarkers into the same radiology/neurology decision-support workflow that SyMRI NEURO addresses.

TypeBroad incumbent
Description

Global MRI OEM co-developing SyMRI 3D with Juntendo University Hospital and distributing SyMRI-compatible scanners. Comparable as a broad MRI incumbent whose AiCE deep-learning reconstruction competes with SyntheticMR's quantitative imaging narrative.

TypeBroad incumbent
Description

German image-guided surgery and neuro-radiotherapy software company with growing AI imaging offerings for the brain. Comparable as a broader neuro-imaging software incumbent with adjacent quantitative imaging and decision-support capabilities.

TypeEmerging player
Description

US-based AI medical imaging company focused on faster MRI acquisition (SubtleMR, SubtleSynth) using deep learning. Emerging peer because it addresses the same MRI throughput and workflow pain points SyntheticMR tackles through synthetic contrast imaging.

TypeEmerging player
Description

Spain/US cloud-based neuroimaging platform providing quantitative analysis and trial-management tools for brain MRI. Emerging peer because it competes for AI-driven brain-imaging quantification and clinical-trial workflows that overlap with cNeuro and SyMRI NEURO.

TypeBroad incumbent
Description

Chinese MRI/CT OEM with a SyMRI integration partnership and growing AI imaging portfolio (uAI). Comparable as a broad incumbent expanding globally whose installed base and AI roadmap increasingly intersect with SyntheticMR's channel.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SyntheticMR

Medical Imaging Software (Quantitative MRI)syntheticmr.com

SyntheticMR firmographics

Firmographics
Name
SyntheticMR
Legal name
SyntheticMR AB
Website
https://syntheticmr.com
Company type
Public
Founded year
2007
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

SyntheticMR industry classification

Industry
Product category
Medical Imaging Software (Quantitative MRI)
NAICS
Medical and Diagnostic Laboratories (62151)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACANAD
Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAF
SaMD – Digital Biomarkers & Algorithmic Endpoints
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Quantitative MRI software
  • Synthetic MRI imaging
  • Brain tissue segmentation
  • Medical imaging software
  • Neuroimaging analysis

Where SyntheticMR is headquartered

Location

Headquarters

HQ city
Linköping
HQ country
Sweden
HQ region
Europe

Offices7 records

Markets served

SyntheticMR business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Software License Sales: SyMRI software sold as product packages (SyMRI NEURO, SyMRI MSK) through direct sales and channel partners. Revenue from software licenses, potentially recurring maintenance/upgrades.
  2. OEM Licensing (GE Healthcare - MAGiC): Customized version of SyMRI IMAGE marketed and sold by GE Healthcare under license agreement. Generates licensing/royalty revenue.
  3. Acquisition Integration (Combinostics): Acquired Combinostics Oy in January 2025 for EUR 4.3 million to integrate cNeuro platform and strengthen AI-based neuroimaging capabilities.

Go-to-market motion3 records

Distribution channels9 records

Marketing channels8 records

SyntheticMR product offering

Product offering

Core offering

SyntheticMR develops and markets SyMRI, a quantitative MRI software platform that produces multiple adjustable contrast-weighted images and absolute tissue property measurements (T1, T2, PD maps) plus automatic brain tissue and myelin segmentations from a single 5-minute MRI scan. The platform is sold in clinically focused packages (SyMRI NEURO for brain imaging, SyMRI MSK for knee and spine, SyMRI IMAGE / MAGiC standard package) and complemented by the cNeuro AI clinical decision-support platform (acquired from Combinostics Oy) for differential diagnosis of cognitive and neurodegenerative disorders.

Product overview

SyntheticMR develops and markets SyMRI, an innovative MRI software platform that delivers multiple adjustable contrast images and quantitative data from a single 5-minute scan. The product portfolio includes SyMRI NEURO (advanced brain imaging with automatic tissue segmentation and myelin quantification, CE-marked and FDA 510(k) cleared), SyMRI MSK (musculoskeletal imaging for knee and spine, CE-marked), and SyMRI IMAGE (standard package with multiple contrast images). The company also offers SyMRI 3D and SyMRI 15 as newer generations. Through its acquisition of Combinostics Oy in January 2025, SyntheticMR expanded to include the cNeuro AI-driven platform with modules for cMRI, cDSI, cPET, and cDAT, combining quantitative MRI with AI-powered clinical decision support for neurological diagnostics. A licensed version, MAGiC, is distributed by GE Healthcare under a license agreement.

Differentiator

Problem solved

Functional benefit

Brands

  • SyMRI: Quantitative MRI software delivering multiple adjustable contrast images and quantitative data from a single scan. Available in different packages including SyMRI NEURO (brain imaging with tissue segmentation and volumetric measurements), SyMRI MSK (knee and spine imaging), and SyMRI IMAGE (general imaging).
  • cNeuro
  • MAGiC
  • SyMap

Products and services

  • SyMRI NEURO Advanced quantitative brain MRI software package that delivers multiple adjustable contrast-weighted images, automatic tissue segmentation (WM, GM, CSF, myelin), volumetric measurements, parametric T1/T2/PD maps and REMyDI myelin quantification from a single scan. CE-marked under EU MDR 2017/745 and FDA 510(k) cleared. Designed for neuroradiology departments, neurology departments and cognitive/memory clinics diagnosing and monitoring MS, dementia, brain tumors, ALS, stroke and pediatric neurological conditions.
  • SyMRI MSK (Spine / Knee) Quantitative musculoskeletal MRI software package delivering multiple contrast-weighted images (T1W, T2W, PDW, STIR) and quantitative T1, T2 and PD maps for knee and spine anatomies in a single 6-minute acquisition. CE-marked. Used by orthopedic and MSK radiologists for cartilage, spine and spinal cord assessment.
  • SyMRI IMAGE Standard quantitative MRI software package delivering up to 8 contrast-weighted images (T1W, T2W, T2W FLAIR, Double Inversion Recovery, Phase Sensitive Inversion Recovery) from a single 6-minute scan, designed to speed up clinical MRI workflow for general imaging use.
  • MAGiC Customer-specific version of SyMRI IMAGE marketed and sold globally by GE Healthcare under a license agreement with SyntheticMR. Available on GE Healthcare's SIGNA MRI systems including SIGNA Pioneer. Generates licensing/royalty revenue for SyntheticMR through OEM distribution.
  • cNeuro AI-driven clinical decision support platform acquired with Combinostics Oy in January 2025. Combines quantitative MRI data with clinical data to support differential diagnosis and disease progression prediction in cognitive disorders such as Alzheimer's and other dementias. Comprises the modules cMRI (automated MRI brain image analysis), cDSI (diagnostic support), cPET (PET image analysis) and cDAT (SPECT/DaTscan analysis), supporting interdisciplinary neurology, radiology and nuclear medicine workflows.

Quantifiable outcome

  • 5-minute scan time vs. multiple conventional sequences
  • +4 more outcomes

Companies that use SyntheticMR

Customer profile

Named customers11 records

Segments4 records

Ideal customer profiles2 records

SyntheticMR technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability7 records

Feature6 records

SyntheticMR partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core and minor.

  • GE HealthcarecoreOEM/ Whitelabel/ Licensing PartnerGE Healthcare markets and sells MAGiC, a customer-specific version of SyMRI IMAGE, under a license agreement. MAGiC is available on GE's SIGNA MRI systems including the SIGNA Pioneer. This is a flagship OEM partnership generating licensing revenue and global distribution through GE's installed base.
  • Siemens HealthineerscoreChannel Partner/ Reseller/ DistributorSyMRI NEURO is available on syngo.via Open Apps from Siemens Healthineers. Collaboration has expanded from initial agreement to direct availability through Siemens Healthineers globally. Also integrated with Siemens Healthineers' Digital Ecosystem.
  • Philips HealthcarecoreChannel Partner/ Reseller/ DistributorGlobal agreement for inclusion of SyMRI in Philips' third party product catalogue. Expanded partnership for SyMRI 3D with joint marketing. SyMRI NEURO compatible with Philips SmartSpeed for accelerated imaging.
  • Canon Medical SystemscoreStrategic or Co-development PartnerJoint development project with Juntendo University Hospital and Canon Medical Systems for SyMRI 3D development. SyMRI compatible with Canon MRI scanners through this partnership.
  • United ImagingminorChannel Partner/ Reseller/ DistributorPartnership agreement and first order received for SyMRI integration with United Imaging MRI systems.
  • FujifilmminorChannel Partner/ Reseller/ DistributorSyMRI product available in Fujifilm's Synapse PACS solution for customers in Japan, providing additional distribution channel in Japanese market.
  • SectraminorChannel Partner/ Reseller/ DistributorSyMRI sold through partnership agreements with Sectra for PACS integration.
  • SimonMed ImagingcoreStrategic or Co-development PartnerNorth American partnership for utilization of SyMRI technology across multiple SimonMed imaging sites. Expanded trials of synthetic MRI testing and expansion of availability.
  • Laureate Institute for Brain ResearchminorStrategic or Co-development PartnerIntegration of SyMRI to support neuropsychiatric research in mood and anxiety disorders using quantitative MRI measures.
  • Mahajan ImagingminorChannel Partner/ Reseller/ DistributorCollaboration agreement for SyMRI utilization in India.
  • Cincinnati Children's Hospital Medical CenterminorStrategic or Co-development PartnerClinical collaboration using SyMRI in pediatric MRI examinations. Dr. Leach leading quantitative MRI implementation for brain development assessment.
  • ProScan ImagingminorChannel Partner/ Reseller/ DistributorIntegration of SyMRI into clinical workflow at ProScan Imaging facilities.
  • Combinostics OycoreStrategic or Co-development PartnerAcquired January 2, 2025 for EUR 4.3 million to integrate Combinostics' cNeuro platform (cMRI, cDSI, cPET, cDAT) and strengthen AI-based neuroimaging capabilities. Jussi Mattila, former CTO of Combinostics, now CTO of SyntheticMR.

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

SyntheticMR competitors and assessment

Company assessment

Broad incumbents

  • GE Healthcare: Global MRI OEM and SyntheticMR's flagship licensing partner — markets MAGiC (a customized version of SyMRI IMAGE) on SIGNA scanners. Directly comparable as a large-scale MRI hardware-and-software incumbent whose AI roadmap overlaps with SyntheticMR's quantitative imaging niche.
  • Siemens Healthineers: Global MRI OEM and reseller of SyMRI NEURO via syngo.via Open Apps. Comparable as a broad incumbent offering AI-enabled imaging suites (AI-Rad Companion) that overlap with SyntheticMR's clinical-decision-support positioning.
  • Philips Healthcare: Global MRI OEM with SyMRI integration through SmartSpeed AI-accelerated imaging and the third-party catalogue. Comparable as a broad incumbent whose AI imaging portfolio competes for the same radiology-department budgets.
  • Canon Medical Systems: Global MRI OEM co-developing SyMRI 3D with Juntendo University Hospital and distributing SyMRI-compatible scanners. Comparable as a broad MRI incumbent whose AiCE deep-learning reconstruction competes with SyntheticMR's quantitative imaging narrative.
  • Brainlab: German image-guided surgery and neuro-radiotherapy software company with growing AI imaging offerings for the brain. Comparable as a broader neuro-imaging software incumbent with adjacent quantitative imaging and decision-support capabilities.
  • United Imaging Healthcare: Chinese MRI/CT OEM with a SyMRI integration partnership and growing AI imaging portfolio (uAI). Comparable as a broad incumbent expanding globally whose installed base and AI roadmap increasingly intersect with SyntheticMR's channel.

Direct peers

  • Icometrix: Belgian specialist in AI-based brain MRI quantification (icobrain) for MS, dementia and traumatic brain injury. Direct peer because it offers MRI brain quantification and clinical decision support in the same neurology workflows SyntheticMR targets with SyMRI NEURO and cNeuro.
  • Cortechs Labs: US-based developer of quantitative MRI post-processing software (NeuroQuant, LesionQuant) for brain volumetrics and lesion tracking. Direct peer because it sells quantitative MRI biomarkers into the same radiology/neurology decision-support workflow that SyMRI NEURO addresses.

Emerging players

  • Subtle Medical: US-based AI medical imaging company focused on faster MRI acquisition (SubtleMR, SubtleSynth) using deep learning. Emerging peer because it addresses the same MRI throughput and workflow pain points SyntheticMR tackles through synthetic contrast imaging.
  • QMENTA: Spain/US cloud-based neuroimaging platform providing quantitative analysis and trial-management tools for brain MRI. Emerging peer because it competes for AI-driven brain-imaging quantification and clinical-trial workflows that overlap with cNeuro and SyMRI NEURO.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

SyntheticMR social profiles

Digital presence

SyntheticMR compliance and trust

Trust signal

Compliance4 records

SyntheticMR financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SyntheticMR leadership team

Management profile

Number of profiles

Profiles10 records

SyntheticMR subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

SyntheticMR funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SyntheticMR M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SyntheticMR

What does SyntheticMR do?

SyntheticMR develops and markets SyMRI, a quantitative MRI software platform that produces multiple adjustable contrast-weighted images and absolute tissue property measurements (T1, T2, PD maps) plus automatic brain tissue and myelin segmentations from a single 5-minute MRI scan. The platform is sold in clinically focused packages (SyMRI NEURO for brain imaging, SyMRI MSK for knee and spine, SyMRI IMAGE / MAGiC standard package) and complemented by the cNeuro AI clinical decision-support platform (acquired from Combinostics Oy) for differential diagnosis of cognitive and neurodegenerative disorders.

Is SyntheticMR a public or private company?

SyntheticMR is a public company. It is classified as public and is currently operating.

When was SyntheticMR founded?

SyntheticMR was founded in 2007. It employs 11 to 50 people.

Where is SyntheticMR based?

SyntheticMR is headquartered in Linköping, Sweden, in the Europe region.

How does SyntheticMR make money?

Three revenue lines are on record. Software License Sales are the primary driver. The others are OEM Licensing (GE Healthcare - MAGiC) and acquisition Integration (Combinostics).

Who are SyntheticMR's main competitors?

Broad incumbents on record are GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Brainlab and United Imaging Healthcare. Direct peers are Icometrix and Cortechs Labs. Emerging players are Subtle Medical and QMENTA.

Does SyntheticMR have an API?

No public API is recorded for SyntheticMR.

What industry is SyntheticMR in?

SyntheticMR's product category is Medical Imaging Software (Quantitative MRI). Its primary akta.pro industry code is HLACANAD, Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software, with a secondary code of HLACANAF, SaMD – Digital Biomarkers & Algorithmic Endpoints. Its NAICS code is 62151 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The future of tradingSyntheticMR Names Nomination Committee for 2027 AGMSyntheticMR appointed a nomination committee for its 2027 annual general meeting. The committee includes Elisabet Tunón, Marcel Warntjes, and Pia Engholm, representing shareholders holding about 35% of the company's shares and votes.news.cision.comNomination Committee appointed for the 2027 Annual General Meeting in SyntheticMR AB (publ)SyntheticMR AB appointed a Nomination Committee for its 2027 Annual General Meeting, with representatives from Swedia Invest AB, Marcel Warntjes, and Panasari AB. The three members are independent and represent about 35% of the company's shares and votes. The committee will propose candidates for the chair and board, as well as auditor remuneration.Dagens industriMinskade förluster för Synthetic MRSynthetic MR reported an operating loss of 6.5 million SEK for Q2 2026, down from 8.6 million SEK. Wellfelt commented on the interest rate situation, calling it a bigger monster than Hormuz.news.cision.comInterim report April – June 2026SyntheticMR reported Q2 2026 net sales of 14.0 MSEK, up 13%, with an operating loss of -6.5 MSEK and net loss of -6.1 MSEK. cMRI ARIA received regulatory approval in the UK and Switzerland, and the company is awaiting FDA feedback on its US review. The company aims to achieve profitability through increased sales and cost control.news.cision.comReport from Annual General Meeting in SyntheticMR AB (publ)SyntheticMR AB's AGM on May 27, 2026 approved no dividend, re-elected four board members, and appointed a Nomination Committee. The company's remaining capitalized funds of SEK 83,334,137 were transferred to new accounts.news.cision.comInterim report January – March 2026SyntheticMR reported Q1 2026 net sales of 13.1 MSEK, down 8% year-over-year, with an operating loss of -6.3 MSEK and net loss of -6.2 MSEK. The company approved a rights issue in January, subscribed to 98.6%, and cMRI ARIA received UK and Swiss regulatory approval in April.openPR.comEmerging Sub-Segments Transforming the Brain Artificial Intelligence (AI)-Assisted Diagnosis Solution MarketThe brain AI-assisted diagnosis solution market is projected to grow to $6.84 billion by 2030, with a compound annual growth rate of 25.5%, driven by increasing demand for early neurological diagnosis and greater adoption of AI diagnostic tools in clinical settings. In January 2025, Swedish healthcare firm SyntheticMR AB acquired Finland-based Combinostics Oy for $5.03 million (€4.3 million) to integrate Combinostics' cNeuro platform and strengthen SyntheticMR's AI-based neuroimaging capabilities in the European market.news.cision.comChange of date for the Annual General Meeting in SyntheticMR AB (publ)SyntheticMR AB (publ) announced that its Board of Directors has rescheduled the Annual General Meeting 2026 from Tuesday, May 12, 2026 to Wednesday, May 27, 2026 at 18:00 CET. The meeting will be held at the company's premises in Linköping, Sweden, with the official notice and annual report for the financial year 2025 to be published separately. This is a routine corporate governance matter with no stated strategic or operational implications.openPR.comGlobal Factors Influencing the Rapid Development of the Brain Imaging Modalities MarketThe brain imaging modalities market is projected to reach $18.55 billion by 2030, growing at a compound annual growth rate of 5.9%, driven by innovations in fMRI, PET, and MRI technologies, along with increasing integration of AI and big data analytics in neuroimaging. GE HealthCare Technologies Inc. completed the acquisition of IMACTIS in April 2023 to strengthen its position in computer-assisted interventional radiology, while Koninklijke Philips N.V. partnered with SyntheticMR in February 2024 to launch Smart Quant Neuro 3D, an AI-powered 3D quantification solution for neuroimaging data. Key trends shaping the industry include growing demand for portable and point-of-care brain imaging devices, specialized pediatric and infant imaging solutions, and expanded use of functional brain imaging in both research and clinical settings.news.cision.comSyntheticMR’s rights issue has been registered – conversion of BTA into sharesSyntheticMR AB announced that its rights issue of shares, with a subscription period that ended on 3 February 2026, has been registered with the Swedish Companies Registration Office, allowing paid subscribed shares (BTA) to be converted into shares. The rights issue, carried out from 20 January to 3 February 2026, raised approximately SEK 32.8 million before issue-related costs. The new shares are expected to be available in shareholders' accounts on 20 February 2026, following the record date of 18 February 2026.